Source: FierceBiotech  St. Jude Medical released new data from a trial that showed patients using its CardioMEMS HF system had a 57% reduction in mortality and 43% fewer hospitalizations related to heart failure compared to patients treated only by guideline directed medical therapy. The St. Paul, MN-based devicemaker said the…...